Commentary: 50 Years of the EORTC – making the difference for the European Oncology Community
28 Aug 2012
Prof Françoise Meunier, Director General, EORTC
In this interview with Mark Lawler, Interlocutor – European Perspectives for The Oncologist, Prof Françoise Meunier, EORTC Director General, recounts some of the successes of the EORTC and identifies key challenges it faces in its pioneering role in the research and treatment of cancer in Europe.
Please also see the accompanying article to this video which appeared in The Oncologist.
Related News
Pink October 2026: Advancing breast cancer research, together
7 Oct 2026
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
